puc-header

A Cytotoxic-Skewed Immune Set Point Predicts Low Neutralizing Antibody Levels After Zika Virus Infection

63 Pages Posted: 10 Feb 2022 Publication Status: Published

See all articles by Elizabeth E. McCarthy

Elizabeth E. McCarthy

University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology

Pamela Odorizzi

University of California, San Francisco (UCSF) - Department of Medicine

Emma Lutz

University of California, San Francisco (UCSF) - Department of Medicine

Carolyn Smullin

University of California, San Francisco (UCSF) - Department of Medicine

Iliana Tenvooren

University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology

Mars Stone

Vitalant Research Institute

Graham Simmons

Vitalant Research Institute

Peter Hunt

University of California, San Francisco (UCSF) - Department of Medicine

Margo Feeney

University of California, San Francisco (UCSF) - Department of Medicine

Philip Norris

Vitalant Research Institute

Michael Busch

Vitalant Research Institute

Matthew H. Spitzer

University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology; Gladstone-UCSF Institute for Genomic Immunology; University of California, San Francisco (UCSF); Parker Institute for Cancer Immunotherapy; Stanford University - Chan Zuckerberg Biohub

Rachel L. Rutishauser

University of California, San Francisco (UCSF) - Department of Medicine

More...

Abstract

Although the generation of high neutralizing antibody levels is a key component of protective immunity after acute viral infection or vaccination, little is known about why some individuals generate high versus low neutralizing antibody titers. We leveraged the high-dimensional single-cell profiling capacity of mass cytometry to characterize the longitudinal cellular immune response to Zika virus (ZIKV) infection in viremic blood donors in Puerto Rico. During acute ZIKV infection, we identified widely coordinated responses across innate and adaptive immune cell lineages. High frequencies of multiple activated cell types during acute infection were associated with high titers of ZIKV neutralizing antibodies 6 months post-infection, while stable immune features suggesting a cytotoxic-skewed immune set point were associated with low titers. Our study offers insight into the coordination of immune responses and identifies candidate cellular biomarkers that may offer predictive value in vaccine efficacy trials aimed at inducing high levels of antiviral neutralizing antibodies.

Keywords: Zika virus, neutralizing antibodies, CyTOF, immune signatures

Suggested Citation

McCarthy, Elizabeth E. and Odorizzi, Pamela and Lutz, Emma and Smullin, Carolyn and Tenvooren, Iliana and Stone, Mars and Simmons, Graham and Hunt, Peter and Feeney, Margo and Norris, Philip and Busch, Michael and Spitzer, Matthew H. and Rutishauser, Rachel L., A Cytotoxic-Skewed Immune Set Point Predicts Low Neutralizing Antibody Levels After Zika Virus Infection. Available at SSRN: https://ssrn.com/abstract=4032072 or http://dx.doi.org/10.2139/ssrn.4032072
This version of the paper has not been formally peer reviewed.

Elizabeth E. McCarthy

University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology ( email )

San Francisco, CA 94143
United States

Pamela Odorizzi

University of California, San Francisco (UCSF) - Department of Medicine ( email )

San Francisco, CA
United States

Emma Lutz

University of California, San Francisco (UCSF) - Department of Medicine ( email )

San Francisco, CA
United States

Carolyn Smullin

University of California, San Francisco (UCSF) - Department of Medicine ( email )

San Francisco, CA
United States

Iliana Tenvooren

University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology ( email )

San Francisco, CA 94143
United States

Mars Stone

Vitalant Research Institute ( email )

San Francisco, 94118
United States

Graham Simmons

Vitalant Research Institute ( email )

San Francisco, 94118
United States

Peter Hunt

University of California, San Francisco (UCSF) - Department of Medicine ( email )

San Francisco, CA
United States

Margo Feeney

University of California, San Francisco (UCSF) - Department of Medicine ( email )

San Francisco, CA
United States

Philip Norris

Vitalant Research Institute ( email )

San Francisco, 94118
United States

Michael Busch

Vitalant Research Institute ( email )

San Francisco, 94118
United States

Matthew H. Spitzer

University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology ( email )

San Francisco, CA 94143
United States

Gladstone-UCSF Institute for Genomic Immunology

San Francisco, CA

University of California, San Francisco (UCSF) ( email )

Third Avenue and Parnassus
San Francisco, CA CA 94143
United States

Parker Institute for Cancer Immunotherapy ( email )

San Francisco, CA
United States

Stanford University - Chan Zuckerberg Biohub ( email )

499 Illinois Street
San Francisco, CA 94158
United States

Rachel L. Rutishauser (Contact Author)

University of California, San Francisco (UCSF) - Department of Medicine ( email )

San Francisco, CA
United States

Click here to go to Cell.com

Paper statistics

Downloads
11
Abstract Views
260
PlumX Metrics